Table 7 Status of application of drug price calculation adjustment factors in the cost accounting method (old)
Ultra-orphan drugs | Orphan drugs | Non-orphan drugs | |
|---|---|---|---|
n = 18 | n = 20 | n = 49 | |
Operating profit markup | |||
60% | 0 | 1 | 0 |
50% | 0 | 0 | 1 |
40% | 0 | 1 | 1 |
35% | 0 | 1 | 0 |
30% | 2 | 0 | 1 |
25% | 0 | 1 | 0 |
20% | 2 | 3 | 5 |
10% | 1 | 2 | 9 |
0% | 13 | 11 | 31 |
−5% | 0 | 0 | 1 |
Foreign average price adjustment | |||
100% raise | 0 | 0 | 0 |
90–99% raise | 0 | 0 | 1 |
80–89% raise | 0 | 0 | 0 |
70–79% raise | 0 | 0 | 0 |
60–69% raise | 0 | 1 | 0 |
50–59% raise | 0 | 0 | 1 |
40–49% raise | 0 | 0 | 0 |
30–39% raise | 0 | 1 | 0 |
20–29% raise | 0 | 0 | 0 |
10–19% raise | 0 | 1 | 0 |
1–9% raise | 0 | 0 | 1 |
Not applicable | 15 | 17 | 41 |
1–9% lowering | 1 | 0 | 0 |
10–19% lowering | 1 | 0 | 1 |
20–29% lowering | 0 | 0 | 0 |
30–39% lowering | 0 | 0 | 3 |
40–49% lowering | 0 | 0 | 0 |
50–59% lowering | 1 | 0 | 0 |
60–69% lowering | 0 | 0 | 1 |
70% and more lowering | 0 | 0 | 0 |